Cambronero Neil MD New York City, NY - 10128

Cambronero Neil MD is categorized under Business Services (Unclassified) in New York City, NY and active since 2013.

Cambronero Neil MD was established in 2013, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.

If you are seeking more information, feel free to contact Neil Cambronero at the company’s single location by writing to 306 East 96th St Apartment 15g, New York City, New York NY 10128 or by phoning (917) 806-0741. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cambronero Neil MD
Contact Person: Neil Cambronero
Address: 306 East 96th St Apartment 15g, New York City, New York 10128
Phone Number: (917) 806-0741
Annual Revenue (USD): $500.000 to $999.999
Founded: 2013
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Services (Unclassified)
SIC Code: 7389
NAICS Code: 561499
Share This Business:

Cambronero Neil MD was started in 2013 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Neil Cambronero for inquiries that concern Cambronero Neil MD by calling the company number (917) 806-0741, as your correspondence is most welcome. Additionally, the physical location of the single location of Cambronero Neil MD can be found at the coordinates 40.784082,-73.946784 as well as the street address 306 East 96th St Apartment 15g in New York City, New York 10128.

For its online presence, you may visit Cambronero Neil MD’s website at and engage with its social media outlets through on Twitter and on Facebook.